Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-02

Clinical Trial Update: Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2

View source ↗

Summary

A clinical trial assessing brain structure and clinical endpoints in myotonic dystrophy type 2 is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Myotonic Dystrophy Type 2, Myotonic Dystrophy Type 1 | Status: RECRUITING